BCWORLD PHARM. Co., Ltd. (KOSDAQ: 200780)

South Korea flag South Korea · Delayed Price · Currency is KRW
5,120.00
+40.00 (0.79%)
Jan 21, 2025, 3:00 PM KST
-20.87%
Market Cap 47.53B
Revenue (ttm) 72.88B
Net Income (ttm) -8.08B
Shares Out 9.28M
EPS (ttm) -869.93
PE Ratio n/a
Forward PE n/a
Dividend 90.91 (1.79%)
Ex-Dividend Date Dec 27, 2024
Volume 13,942
Average Volume 12,911
Open 5,200.00
Previous Close 5,080.00
Day's Range 4,960.00 - 5,200.00
52-Week Range 3,890.00 - 7,460.00
Beta -0.16
RSI 68.50
Earnings Date Feb 13, 2025

About BCWORLD PHARM.

BCWORLD PHARM. Co., Ltd. operates as a pharmaceutical company in South Korea. The company provides products in various therapeutic areas comprising musculoskeletal system, digestive system, circulatory machine, central nervous system, adrenocorticosteroids, narcotic analgesics, erectile dysfunction treatment, wellbeing injection, diuretic, antitussive expectorant, vaginitis treatment, anti-tuberculosis drugs, anti-emetic, antiviral drugs, antibiotic, anti-malignant tumor drugs, antifungal agent, antihistamines, antidote, and antipyretic/analges... [Read more]

Industry Pharmaceutical Preparations
Founded 1980
Employees 284
Stock Exchange KOSDAQ
Ticker Symbol 200780
Full Company Profile

Financial Performance

In 2023, BCWORLD PHARM.'s revenue was 75.11 billion, an increase of 3.31% compared to the previous year's 72.70 billion. Earnings were 2.63 billion, an increase of 836.31%.

Financial Statements

News

There is no news available yet.